BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6310077)

  • 1. Total body clearance of circulating benzo(a)pyrene in conscious rats: effect of pretreatment with 3-methylcholanthrene and the role of liver and lung.
    Wiersma DA; Roth RA
    J Pharmacol Exp Ther; 1983 Sep; 226(3):661-7. PubMed ID: 6310077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clearance of benzo(a)pyrene by isolated rat liver and lung: alterations in perfusion and metabolic capacity.
    Wiersma DA; Roth RA
    J Pharmacol Exp Ther; 1983 Apr; 225(1):121-5. PubMed ID: 6300370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prediction of benzo[a]pyrene clearance by rat liver and lung from enzyme kinetic data.
    Wiersma DA; Roth RA
    Mol Pharmacol; 1983 Sep; 24(2):300-8. PubMed ID: 6310365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fate of intratracheally installed benzo(a)pyrene in the isolated perfused rat lung of both control and 20-methylcholanthrene pretreated rats.
    Vainio H; Uotila P; Hartiala J; Pelkonen O
    Res Commun Chem Pathol Pharmacol; 1976 Feb; 13(2):259-71. PubMed ID: 1257613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of nicotine on benzo(a)pyrene elimination and marked pulmonary metabolism of nicotine in isolated perfused rat lung.
    Foth H; Rüdell U; Ritter G; Kahl GF
    Klin Wochenschr; 1988; 66 Suppl 11():98-104. PubMed ID: 3184783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzo(a)pyrene disposition and metabolism in rats following intratracheal instillation.
    Weyand EH; Bevan DR
    Cancer Res; 1986 Nov; 46(11):5655-61. PubMed ID: 3756912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Covalent binding of benzo(a)pyrene in perfused rat lung following systemic and intratracheal administration.
    Foth H; Mollière M; Kahl R; Jähnchen E; Kahl GF
    Drug Metab Dispos; 1984; 12(6):760-6. PubMed ID: 6150827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzo(a)pyrene phenol production by perfused rat liver and its inhibition by ethanol.
    Reinke LA; McManus P; Kauffman FC; Thurman RG
    Cancer Res; 1982 May; 42(5):1681-5. PubMed ID: 6279282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the induction by extracts from airborne particulates of benzo(a)pyrene hydroxylase and the binding of benzo(a)pyrene to DNA in the rat lung in vivo after pertracheal administration (author's transl)].
    Dehnen W; Verbücheln J
    Zentralbl Bakteriol Mikrobiol Hyg B; 1981 Dec; 174(3):260-73. PubMed ID: 6277103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo O-de-ethylation of phenacetin in 3-methylcholanthrene-pretreated rats: gut wall and liver first-pass metabolism.
    Klippert PJ; Littel RJ; Noordhoek J
    J Pharmacol Exp Ther; 1983 Apr; 225(1):153-7. PubMed ID: 6834267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemistry, physiology and drug metabolism--implications regarding the role of the lungs in drug disposition.
    Roth RA
    Clin Physiol Biochem; 1985; 3(2-3):66-79. PubMed ID: 3891197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of simultaneously administered antipyrine and theophylline in male BN/BiRij rats before and after induction with 3-methylcholanthrene.
    Groen K; Breimer DD; van Bezooijen CF
    Drug Metab Dispos; 1992; 20(4):502-6. PubMed ID: 1356725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake and excretion of benzo[a]pyrene and its metabolites by the rat pancreas.
    Iqbal ZM; Yoshida A; Epstein SS
    Drug Metab Dispos; 1979; 7(1):44-8. PubMed ID: 35326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic metabolism of benzo(a)pyrene in vitro and in vivo in the Long-Evans rat.
    Black O; Murrill E; Pallas F
    Res Commun Chem Pathol Pharmacol; 1980 Aug; 29(2):291-307. PubMed ID: 7414050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovotoxicity in female Fischer rats and B6 mice induced by low-dose exposure to three polycyclic aromatic hydrocarbons: comparison through calculation of an ovotoxic index.
    Borman SM; Christian PJ; Sipes IG; Hoyer PB
    Toxicol Appl Pharmacol; 2000 Sep; 167(3):191-8. PubMed ID: 10986010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of red blood cells, serum albumin, and serum lipoproteins on the clearance of benzo[alpha]pyrene by isolated livers of 3-methylcholanthrene-treated rats.
    Wiersma DA; Stemmer PM; Roth RA
    Biochem Pharmacol; 1984 Nov; 33(21):3433-8. PubMed ID: 6497903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of benzo(a)pyrene metabolite:DNA adducts in lung and liver of mice.
    Kulkarni MS; Anderson MW
    Cancer Res; 1984 Jan; 44(1):97-101. PubMed ID: 6317174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinogenesis, benzo[a]pyrene metabolism, and sister chromatid exchanges in lungs of rats after intratracheal 3-methylcholanthrene.
    Rasmussen RE; Anderson J; Kinkead ER; MacEwen JD; Bruner RH
    J Natl Cancer Inst; 1984 Jul; 73(1):257-64. PubMed ID: 6330422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of flow on the metabolism of perfused benzo[a]pyrene by isolated rat lung.
    Wiersma DA; Braselton WE; Roth RA
    Chem Biol Interact; 1983 Jan; 43(1):1-15. PubMed ID: 6295648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of pulmonary benzo(a)pyrene 4,5-oxide clearance: a pharmacokinetic analysis of epoxide-metabolizing enzymes in rabbit lung.
    Smith BR; Bend JR
    J Pharmacol Exp Ther; 1980 Sep; 214(3):478-82. PubMed ID: 7190605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.